Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

Capacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience.

Read this article at

ScienceOpenPublisherPubMed
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      Despite an estimated 456,000 deaths caused by cancer in sub-Saharan Africa in 2012 and a cancer burden that is predicted to double by 2030, the region accounts for only 0·3% of worldwide medical expenditure for cancer. Challenges to cancer care in sub-Saharan Africa include a shortage of clinicians and training programmes, weak healthcare infrastructure, and inadequate supplies. Since 2011, Rwanda has developed a national cancer programme by designing comprehensive, integrated frameworks of care, building local human resource capacity through partnerships, and delivering equitable, rights-based care. In the 2 years since the inauguration of Rwanda's first cancer centre, more than 2500 patients have been enrolled, including patients from every district in Rwanda. Based on Rwanda's national cancer programme development, we suggest principles that could guide other nations in the development of similar cancer programmes.

      Related collections

      Author and article information

      Affiliations
      [1 ] Brigham and Women's Hospital, Boston, MA, USA. Electronic address: sstulac@pih.org.
      [2 ] Ministry of Health of Rwanda, Kigali, Rwanda.
      [3 ] Brigham and Women's Hospital, Boston, MA, USA.
      [4 ] Global Health Delivery Partnership, Boston, MA, USA.
      [5 ] Inshuti Mu Buzima, Rwinkwavu, Rwanda.
      [6 ] Dana-Farber Cancer Institute, Boston, MA, USA.
      [7 ] Partners In Health, Boston, MA, USA.
      [8 ] University of Rwanda College of Medicine and Health Services, Kigali, Rwanda.
      [9 ] Harvard Medical School, Boston, MA, USA.
      Journal
      Lancet Oncol.
      The Lancet. Oncology
      Elsevier BV
      1474-5488
      1470-2045
      Aug 2015
      : 16
      : 8
      26248848
      S1470-2045(15)00161-8
      10.1016/S1470-2045(15)00161-8

      Comments

      Comment on this article